Receipt of Binding Commitments for $4.5m Placement
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Neurotech International Ltd. has announced the receipt of binding commitments for a capital placement aimed at raising funds for its clinical trial efforts. The placement involves the issuance of new shares and has garnered interest from both existing and new investors. Neurotech's Managing Director expressed satisfaction with the support received, which will help advance their clinical program.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Neurotech International Ltd. on 6ix
Story so far
Earlier from Neurotech International
- Neurotech secures $3.15 million R&D tax incentive loan
- US FDA clears IND for NTI164
- NTI secures Notices of Allowance for US patent applications
- NTI initiates First Clinical Site for Phase 3 ASD Trial
- Appendix 4D & Half Year Report
Later from Neurotech International
- NTI Doses First Patient in Phase 3 Beyond Harmony ASD Study
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International